Rheumatoid arthritis can be effective after several injections of Adalimumab

Adalimumab is a humanized monoclonal antibody against tumor necrosis factor α (TNF-α) and is widely used in the treatment of rheumatoid arthritis (RA). By inhibiting TNF-α, it reduces the inflammatory response, blocks the progression of the disease, and achieves the effect of relieving joint pain, swelling and improving function. Many patients and doctors are concerned about how many times it takes to take effect after using Adalim. This is one of the important indicators for evaluating the effect of treatment.

Generally, adalimumab has a faster onset of action. Most patients can feel significant improvement in joint pain and swelling within 4 to 8 weeks after the first injection, and some patients even experience relief of symptoms after the 2 injection. Clinical studies have shown that when adalimumab is combined with traditional disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, the efficacy is more significant and lasting. Early positive responses often indicate stable long-term efficacy.

However, some patients may have a slower onset of effect due to individual differences, disease severity, or comorbidities, and may need to continue taking the medication for 3 months or even longer before significant improvement is observed. In the early stages of treatment, doctors will regularly assess disease activity and functional status based on the patient's specific conditions, adjust the dose or combine it with other treatment options to achieve the best treatment effect.

In short, the onset of effect of adalimumab in the treatment of rheumatoid arthritis varies from person to person, but most patients can feel symptom relief within 1 to 2 months. Patients should remain patient, take medications regularly according to doctor's instructions, and follow up regularly, as well as cooperate with lifestyle adjustments and rehabilitation exercises to obtain better treatment effects and quality of life.

Reference materials:https://www.drugs.com